Sandu Pharmaceuticals Stock Screener | Share Price & Fundamental Analysis
SANDUPHQ
Pharmaceuticals
Share Price BSE
₹35.60
▲
0.60 (1.71%)
Track Sandu Pharmaceuticals share price live with TickJournal's free stock screener.
Analyze Sandu Pharmaceuticals share price history trends and compare 52-week high low
levels.
Calculate SANDUPHQ stock fair value using fundamental analysis and view live share price charts.
Determine Sandu Pharmaceuticals share intrinsic value and compare it with current SANDUPHQ share price.
Record your Sandu Pharmaceuticals trades in TickJournal's free trading journal and track your portfolio performance.
Sandu Pharmaceuticals Market Cap
₹37.70 Cr.
SANDUPHQ P/E Ratio (TTM)
15.00
EPS (TTM)
₹1.60
Dividend Yield
2.05%
Debt to Equity
-
SANDUPHQ 52 Week High
₹56.91
Sandu Pharmaceuticals 52 Week Low
₹31.79
Operating Margin
3.00%
Profit Margin
-
SANDUPHQ Revenue (TTM)
₹14.00
EBITDA
₹1.00
Net Income
-
Total Assets
₹56.00
Total Equity
₹42.00
Sandu Pharmaceuticals Share Price History - Stock Screener Chart
Screen SANDUPHQ historical share price movements with interactive charts. Analyze price trends and patterns.
Sandu Pharmaceuticals Company Profile - Fundamental Screener
Screen Sandu Pharmaceuticals company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for SANDUPHQ shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE751D01014
Sandu Pharmaceuticals Balance Sheet Screener
Screen SANDUPHQ balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 |
|---|---|---|---|
| Assets | |||
| Total Assets | 56 | 52 | 54 |
| Current Assets | 26 | 22 | 26 |
| Fixed Assets | 18 | 18 | 17 |
| Liabilities | |||
| Total Liabilities | 56 | 52 | 54 |
| Current Liabilities | 2 | 1 | 1 |
| Non-Current Liabilities | 0 | 0 | 0 |
| Shareholders' Equity | |||
| Total Equity | 42 | 41 | 39 |
| Share Capital | 10 | 10 | 10 |
| Reserves & Surplus | 32 | 31 | 30 |
Sandu Pharmaceuticals Income Statement Screener - Profit & Revenue Analysis
Screen Sandu Pharmaceuticals income statement and profit fundamentals.
Analyze SANDUPHQ quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Sandu Pharmaceuticals share price evaluation.
| Item | 2025-Mar | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept | 2022-Dec | 2021-Jun | 2021-Sept |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 14 | 16 | 17 | 18 | 18 | 15 | 18 | 17 | 18 | 12 | 16 | 17 | 17 | 17 | 18 |
| Expenses | 14 | 15 | 17 | 17 | 17 | 15 | 17 | 16 | 17 | 11 | 16 | 16 | 16 | 17 | 17 |
| EBITDA | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 |
| Operating Profit % | 3.00% | 4.00% | 2.00% | 5.00% | 5.00% | 3.00% | 2.00% | 5.00% | 3.00% | 5.00% | 2.00% | 5.00% | 5.00% | 4.00% | 5.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 0 |
| EPS | 0.34 | 0.62 | 0.17 | 1.95 | 0.57 | 0.26 | 0.11 | 0.57 | 0.21 | 0.34 | 0.19 | 0.64 | 0.51 | 0.53 | 0.57 |
Sandu Pharmaceuticals Cash Flow Screener - Liquidity Fundamentals
Screen SANDUPHQ cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March |
|---|---|---|---|
| Operating Activities | 1 | 1 | 0 |
| Investing Activities | 0 | -1 | 1 |
| Financing Activities | -1 | -1 | 1 |
| Net Cash Flow | 0 | -1 | 1 |
Sandu Pharmaceuticals Shareholding Pattern Screener
See Sandu Pharmaceuticals shareholding pattern with promoter, FII, and DII holdings.
Check Sandu Pharmaceuticals promoter holding and ownership changes for SANDUPHQ on TickJournal.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 42.90% | 42.90% | 42.90% | 42.90% | 42.90% | 42.90% | 42.90% | 52.41% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 35.90% | 36.57% | 36.77% | 44.16% | 44.25% | 34.97% | 35.34% | 35.72% |
| Other Holding | 21.20% | 20.53% | 20.32% | 12.93% | 12.84% | 22.12% | 21.75% | 11.86% |
| Shareholder Count | 10,287 | 10,226 | 10,284 | 10,001 | 10,012 | 10,246 | 10,333 | 10,141 |
Sandu Pharmaceuticals Share Dividend Screener - Share Yield Analysis
Check Sandu Pharmaceuticals dividend history with payout and yield data.
View Sandu Pharmaceuticals dividend details including ex-dates and amounts for SANDUPHQ stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2025-March | ₹0.80 | 2.05% |
| 2024-March | ₹0.80 | 1.63% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.75 | 1.43% |
| 2021-March | ₹0.50 | 0.71% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
| 2016-March | ₹0.00 | 0.00% |
Sandu Pharmaceuticals Stock Index Membership
See which indices include Sandu Pharmaceuticals stock.
Check SANDUPHQ index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Sandu Pharmaceuticals Market Events Screener - Corporate Actions
Get Sandu Pharmaceuticals corporate actions including splits, bonuses, and buybacks.
Check Sandu Pharmaceuticals stock events that may affect SANDUPHQ share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Dividend | ₹ 0.80 /share | -12.97% | ||
| Dividend | ₹ 0.75 /share | 5.08% | ||
| Dividend | ₹ 0.75 /share | 41.02% | ||
| Dividend | ₹ 0.80 /share | 4.55% | ||
| Annual General Meeting | NA | 3.42% | ||
| Dividend | ₹ 0.50 /share | 0.87% | ||
| Annual General Meeting | NA | -3.84% | ||
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | -2.51% |
| 2025-08-13 | 2025-08-13 | Quarterly Result Announcement | NA | 0.76% |
| 2025-05-28 | 2025-05-28 | Quarterly Result Announcement | NA | 4.41% |
| 2025-02-13 | 2025-02-13 | Quarterly Result Announcement | NA | -3.54% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | 2.33% |
Sandu Pharmaceuticals Competitors Screener - Peer Comparison
Screen SANDUPHQ competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 427,394 | 40.80 | 54,729 | 9.71% | 10,980 | 52.10 |
| Divis Laboratories | 168,188 | 67.69 | 9,712 | 18.67% | 2,191 | 43.07 |
| Torrent Pharmaceuticals | 127,428 | 59.43 | 11,539 | 6.99% | 1,911 | 54.16 |
| Cipla | 121,131 | 22.30 | 28,410 | 7.12% | 5,291 | 43.47 |
| Dr Reddys Laboratories | 106,572 | 18.61 | 33,741 | 16.73% | 5,725 | 58.35 |
| Lupin | 95,489 | 21.96 | 22,910 | 13.74% | 3,306 | 58.83 |
| Zydus Life Science | 92,005 | 18.29 | 23,511 | 18.55% | 4,615 | 35.18 |
| Mankind Pharma | 86,927 | 49.02 | 12,744 | 20.90% | 2,007 | 25.12 |
| Aurobindo Pharma | 68,424 | 20.00 | 32,346 | 9.43% | 3,484 | 47.36 |
| Alkem Laboratories | 67,716 | 28.08 | 13,458 | 3.70% | 2,216 | 52.38 |
Sandu Pharmaceuticals Company Announcements - News Screener
Screen SANDUPHQ latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2025-11-19 | : Intimation Regarding Receipt Of Approval Of Shareholders For Reclassification Of M/S Akshath Finvest And Properties Private Limited Persons Forming Part Of The Promoter/Promoter Group Category To The Public Category. | View |
| 2025-11-19 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | View |
| 2025-11-19 | Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot | View |
| 2025-11-14 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-12 | Statement Of Deviation And Variation For The Quarter Ended 30.09.2025 | View |
| 2025-11-12 | Unaudited Financial Results For The Q And Half Year Ended 30.09.2025 | View |
| 2025-11-12 | Board Meeting Outcome for Outcome Of The Board Meeting Dated 12.11.2025 | View |
| 2025-11-05 | Board Meeting Intimation for Approval Of Standalone Unaudited Financial Results For Quarter And Half Year Ended 30Th September 2025 | View |
| 2025-10-18 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-10-18 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-10-17 | Shareholder Meeting / Postal Ballot-Notice of Postal Ballot | View |
| 2025-10-14 | Approval Of The Draft Postal Ballot Notice And Explanatory Statement | View |
| 2025-10-14 | Board Meeting Outcome for Outcome Of The Board Meeting Dated 14Th October 2025 | View |
| 2025-10-07 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-10-04 | Board Meeting Intimation for 1. To Approve Notice Of Postal Ballot For Reclassification Of M/S Akshath Finvest And Properties Private Limited From Promoter/ Promoter Group Category To Public Category | View |
| 2025-10-01 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-10-01 | Announcement Under Regulation 30-Appointment Of Secretarial Auditor | View |
| 2025-10-01 | Announcement Under Regulation 30-Update-Agenda Items Approved By Shareholders At The 40Th Annual General Meeting | View |
| 2025-10-01 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-09-30 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |